questionText: To ask the Secretary of State for Health and Social Care, what progress his Department has made on reviewing regulations of treatments for rare diseases and orphan drugs as required by the Rare Cancers Act 2026.
answerText: Following the launch of the new rare disease therapy framework, the Department has made significant progress in reviewing and proposing updates to the regulation of treatments for rare diseases and orphan drugs. Building on earlier policy commitments, the...
heading: Rare Cancers